News & Research

Hyperbaric Oxygen Therapy has been used for the better part of two centuries. Search our  arhives below for past HBOT news and research or scroll down for the latest.

The Latest HBOT News & Research

Clinical Trial – Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects

The investigators intend to determine if patients that are already undergoing Hyperbaric
Oxygen (HBO) therapy one year post treatment with radiation therapy for head and neck cancer,
experience improvement in xerostomia and/or taste alteration. The investigators will enroll a
similar demographic one year post treatment with radiation therapy that does not receive HBO
therapy. This is a quality of life study.

Clinical Trial – Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain

Currently, opioids are widely used for pain relief, but they often provide sub-optimal
analgesia with occasional serious side effects. Preservative-free ketamine hydrochloride was
introduced as a spinal anesthetic more than twenty years ago and found to have advantages
over local anesthetics. Intrathecal dexmedetomidine provides an analgesic effect in
postoperative pain without severe sedation. The objectives of this study were to compare the
efficacy and safety of intrathecally administered dexmedetomidine, ketamine, or their
combination when added to bupivacaine for postoperative analgesia in major abdominal cancer
surgery.

Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease

Recent studies have suggested that nitric oxide (NO.), the product of nitric oxide synthase in inflammatory cells, may play a part in tissue injury and inflammation through its oxidative metabolism. In this study the colonic generation of oxides of nitrogen (NOx) and nitric oxide synthase activity was determined in ulcerative colitis and Crohn’s disease. Colonic biopsy specimens were obtained from inflammatory bowel disease patients and from normal controls. Mucosal explants were cultured in vitro for 24 hours and NOx generation was determined. Nitric oxide synthase activity was monitored by the conversion of [3H]-L-arginine to citrulline. Median NOx generation by inflamed colonic mucosa of patients with active ulcerative colitis and Crohn’s colitis was 4.2- and 8.1-fold respectively higher than that by normal human colonic mucosa. In ulcerative colitis and Crohn’s colitis nitric oxide synthase activity was 10.0- and 3.8-fold respectively higher than in normal subjects.